Patents Assigned to Corralluma LLC
  • IR700 Nanocompositions for Cardiac Therapies and Applications
    Publication number: 20210085790
    Abstract: A nanocomposition for use in treating a cardiac condition using phthalocyanine dye, such as IR700. A nanocomposition having IR700, an 8PEG nanoparticle and a cardiac targeting peptide. Administering a product comprising IR700 to a patient, whereby the IR700 is delivered to cardiac tissue, and found in only cardiac tissue; and administering light to activate the IR700, thereby producing an ROS.
    Type: Application
    Filed: April 10, 2020
    Publication date: March 25, 2021
    Applicant: Corralluma LLC
    Inventors: Thomas Hopkins, Andrew Hopkins